What causes pulmonary hypertension, and can it be treated?
Pulmonary hypertension generally refers to pulmonary arterial hypertension. Pulmonary arterial hypertension can be caused by genetic factors, environmental factors, chronic obstructive pulmonary disease (COPD), and other reasons. Treatment measures should be tailored according to the underlying cause.
1. Genetic Factors
Congenital heart disease, if not treated properly and promptly, can easily trigger secondary pulmonary arterial hypertension, such as left ventricular hypertrophy and valvular heart disease. For mild cases, medications such as isosorbide mononitrate sustained-release tablets, compound amiloride hydrochloride tablets, and losartan potassium capsules may be used under medical guidance for control. Severe cases may require surgical interventions such as heart valve repair or balloon atrial septostomy.
2. Environmental Factors
Long-term exposure to low-pressure, low-oxygen environments can also increase the incidence of this condition. Patients should avoid adverse environmental conditions and receive combined treatments including oxygen therapy, rehabilitation exercises, and medication. Medications such as dobutamine tablets and digoxin tablets, prescribed by a physician, can enhance myocardial cell function and slow disease progression.
3. Chronic Obstructive Pulmonary Disease (COPD)
COPD leads to reduced lung function and chronically low blood oxygen levels. Affected patients are highly susceptible to developing secondary elevation in pulmonary arterial pressure. Under medical supervision, patients may use drugs such as salmeterol fluticasone inhalation powder, fudosteine tablets, and ambroxol clenbuterol oral solution to improve airway gas exchange and relieve symptoms such as chest tightness, shortness of breath, and coughing.
Other diseases, such as lung squamous cell carcinoma, can also lead to the above-mentioned conditions. Patients must undergo hospital evaluation and diagnosis before definitive treatment can be initiated.
